Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Iron Chelator (Desferal) to Reduce the Severity of COVID-19 Manifestations

NCT04333550 is registered in ClinicalTrials.gov with Kermanshah University of Medical Sciences as lead sponsor.

NCT NCT04333550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Iron Chelator (Desferal) to Reduce the Severity of COVID-19 Manifestations
Lead sponsor
Kermanshah University of Medical Sciences
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2020
Completion date
March 31, 2021
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19